#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17384	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2581	829.9	0	.	n	.	0	A69G	SNP	69	69	A	544	544	G	1062	G,A,C,T	791,265,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17384	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2581	829.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1925	1925	T	1157	T,G,C	1149,5,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17384	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2581	829.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1659	1659	C	1037	C	1037	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17384	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2581	829.9	0	HET	.	.	.	T454TG	.	454	454	T	929	929	T	1138	TG,T	818,298	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17384	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2581	829.9	0	HET	.	.	.	G1266T	.	1266	1266	G	1741	1741	G	1069	G,T	855,214	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29580	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4198	880.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1962	1962	A	1213	A,G	1211,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29580	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4198	880.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2596	2596	C	1075	C,T,A	1072,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29580	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4198	880.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2670	2670	A	969	A,T	968,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29580	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4198	880.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3222	3222	C	1048	C,A	1047,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2644	folP	852	852	99.88	folP.l15.c4.ctg.1	2124	155.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1153	1155	AAA	260;259;259	A;A;A	260;259;259	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2644	folP	852	852	99.88	folP.l15.c4.ctg.1	2124	155.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1384	1386	AGC	258;259;253	A;G;C,T	258;259;252,1	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5712	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3955	180.2	1	SNP	p	S91F	0	.	.	271	273	TCC	861	863	TCC	199;196;201	T;C;C	199;196;201	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5712	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3955	180.2	1	SNP	p	D95G	0	.	.	283	285	GAC	873	875	GAC	202;204;205	G;A;C	202;204;205	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5712	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3955	180.2	1	SNP	p	D95N	0	.	.	283	285	GAC	873	875	GAC	202;204;205	G;A;C	202;204;205	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2390	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1847	161.3	1	SNP	p	G45D	0	.	.	133	135	GGC	722	724	GGC	273;272;272	G,C;G;C	272,1;272;272	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1250	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1667	93.6	0	.	n	.	0	A197.	DEL	197	197	A	958	958	A	251	A	250	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6036	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3499	215.2	1	SNP	p	D86N	0	.	.	256	258	GAC	864	866	GAC	239;242;242	G,C;A;C	238,1;242;242	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6036	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3499	215.2	1	SNP	p	S87W	0	.	.	259	261	AGT	867	869	AGT	242;241;242	A,C;G;T,G	241,1;241;241,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6036	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3499	215.2	1	SNP	p	S87R	0	.	.	259	261	AGT	867	869	AGT	242;241;242	A,C;G;T,G	241,1;241;241,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6036	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3499	215.2	1	SNP	p	S87I	0	.	.	259	261	AGT	867	869	AGT	242;241;242	A,C;G;T,G	241,1;241;241,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	6036	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3499	215.2	1	SNP	p	S88P	0	.	.	262	264	TCC	870	872	TCC	243;244;245	T;C;C,T,G	243;244;243,1,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5198	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3229	200.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1770	1772	GGC	256;253;251	G;G,T;C	256;252,1;251	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1531	1533	GCA	248;251;253	G,A;C;A	247,1;251;253	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1534	1536	ATC	255;254;252	A;T,A;C	255;253,1;252	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1546	1548	GTG	253;253;256	G;T;G	253;253;256	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1546	1548	GTG	253;253;256	G;T;G	253;253;256	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2050	2052	ACC	252;251;251	A;C;C	252;251;251	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2104	2106	GCG	274;273;273	G;C;G,A,T,C	274;273;270,1,1,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2104	2106	GCG	274;273;273	G;C;G,A,T,C	274;273;270,1,1,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2227	2229	GGC	261;262;265	G;G;C	261;262;265	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2236	2238	GGC	263;265;264	G;G;C	263;265;264	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4532	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2983	189.7	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2254	2256	CTG	270;271;274	C,T;T,C;G,A	269,1;270,1;273,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6676	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3659	227.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1922	1924	CCG	281;285;286	C;C;G	281;285;286	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3038	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2262	167.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	797	797	C	222	C,G	221,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	36;37;39	T;T;A	36;37;39	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	75;75;75	C;A;T	75;75;75	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	75;75;75	A;G;T	75;75;75	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	75;75;75	T;A;C	75;75;75	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	1;2;2	G;A;C	1;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	356	porB1a	984	226	90.27	porB1a.l15.c30.ctg.1	361	37.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	795	797	GAA	306;303;310	G;A;A	306;303;310	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1083	1085	GAT	300;297;295	G,T,C;A;T	298,1,1;297;295	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1206	1208	TCA	301;302;307	T,G;C;A,G	300,1;302;306,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1335	1337	GTC	270;270;274	G;T;C	270;270;274	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1347	1349	TCT	274;277;276	T;C;T	274;277;276	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1665	1667	GCA	275;273;272	G,A;C,A;A,T,C	274,1;271,2;270,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	1	SNP	p	G120K	1	.	.	358	360	AAG	1041	1043	AAG	290;291;295	A;A,G;G	290;289,2;295	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	1	SNP	p	A121D	1	.	.	361	363	GAC	1044	1046	GAC	293;296;299	G;A;C,T	293;296;298,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3458	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2080	206.7	1	SNP	p	D121N	0	.	.	361	363	GAC	1044	1046	GAC	293;296;299	G;A;C,T	293;296;298,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11718	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5432	269.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2272	2274	AAT	310;310;312	A,C;A;T	309,1;310;312	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1698	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1479	142.9	1	SNP	p	V57M	1	.	.	169	171	ATG	749	751	ATG	296;296;293	A;T,G;G	296;295,1;293	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
